Investigational Drug Treatments for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) and accounts for 10–20% of cases. Due to the lack of expression of several receptors, hormone therapy is largely ineffective for treatment purposes. Nevertheless, TNBC often responds very well to chemotherapy, which...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pers Med
Autors principals: Damaskos, Christos, Garmpis, Nikolaos, Garmpi, Anna, Nikolettos, Konstantinos, Sarantis, Panagiotis, Georgakopoulou, Vasiliki E., Nonni, Afroditi, Schizas, Dimitrios, Antoniou, Efstathios A., Karamouzis, Michalis V., Nikolettos, Nikos, Kontzoglou, Konstantinos, Patsouras, Alexandros, Voutyritsa, Errika, Syllaios, Athanasios, Koustas, Evangelos, Trakas, Nikolaos, Dimitroulis, Dimitrios
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303312/
https://ncbi.nlm.nih.gov/pubmed/34357119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11070652
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars